Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 4
2003 7
2004 4
2005 9
2006 10
2007 4
2008 3
2009 5
2010 7
2011 6
2012 5
2013 4
2014 7
2015 5
2016 5
2017 6
2018 2
2019 7
2020 3
2021 2
2022 7
2023 10
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Cancer immunotherapy.
Baxevanis CN, Perez SA, Papamichail M. Baxevanis CN, et al. Crit Rev Clin Lab Sci. 2009;46(4):167-89. doi: 10.1080/10408360902937809. Crit Rev Clin Lab Sci. 2009. PMID: 19650714 Free article. Review.
Combination Immunotherapy in Prostate Cancer.
Baxevanis CN, Goulielmaki M, Gritzapis AD, Fortis SP. Baxevanis CN, et al. Cancers (Basel). 2022 Dec 8;14(24):6040. doi: 10.3390/cancers14246040. Cancers (Basel). 2022. PMID: 36551526 Free PMC article.
Biomarkers in the Era of Precision Oncology.
Baxevanis CN. Baxevanis CN. Cancers (Basel). 2023 Mar 15;15(6):1782. doi: 10.3390/cancers15061782. Cancers (Basel). 2023. PMID: 36980668 Free PMC article.
Radiotherapy-Related Gene Signature in Prostate Cancer.
Fortis SP, Goulielmaki M, Aubert N, Batsaki P, Ouzounis S, Cavouras D, Marodon G, Stokidis S, Gritzapis AD, Baxevanis CN. Fortis SP, et al. Among authors: baxevanis cn. Cancers (Basel). 2022 Oct 14;14(20):5032. doi: 10.3390/cancers14205032. Cancers (Basel). 2022. PMID: 36291815 Free PMC article.
HER-2/neu as a target for cancer vaccines.
Baxevanis CN, Voutsas IF, Gritzapis AD, Perez SA, Papamichail M. Baxevanis CN, et al. Immunotherapy. 2010 Mar;2(2):213-26. doi: 10.2217/imt.09.89. Immunotherapy. 2010. PMID: 20635929 Review.
AE37: a novel T-cell-eliciting vaccine for breast cancer.
Sears AK, Perez SA, Clifton GT, Benavides LC, Gates JD, Clive KS, Holmes JP, Shumway NM, Van Echo DC, Carmichael MG, Ponniah S, Baxevanis CN, Mittendorf EA, Papamichail M, Peoples GE. Sears AK, et al. Among authors: baxevanis cn. Expert Opin Biol Ther. 2011 Nov;11(11):1543-50. doi: 10.1517/14712598.2011.616889. Epub 2011 Sep 6. Expert Opin Biol Ther. 2011. PMID: 21895539 Review.
103 results